共信-KY (6617)

About 共信-KY

Gongwin Biopharm Holdings Co., Ltd., a clinical-stage biopharmaceutical company, develops anticancer drugs in Hong Kong, China, and Singapore. It is developing PTS302, which has completed Phase III clinical trials for the treatment of lung cancer; PTS100, which is in Phase II clinical trials for the treatment of hepatocellular carcinoma; PTS02, which is in Phase I clinical trials for the treatment of adenoid cystic carcinoma; and PTS500 for the treatment of malignant pleural effusion. The company also develops animal medicines; engaged in the pet medical business; and wholesale and retail of the medical equipment. Gongwin Biopharm Holdings Co., Ltd. was founded in 2014 and is based in Taipei, Taiwan.

Headquarters: Taipei, TW · Website: https://www.gongwinbiopharm.com

Product categories

• Harmonic Drives / Precision Reducers

Competitors of 共信-KY

• ALLIENT INC (ALNT)
• CKD Corporation (6407.T)
• DANA Inc (DAN)
• Han's Laser Technology Industry Group Co., Ltd. (002008.SZ)
• Harmonic Drive Systems Inc. (6324.T)
• Hirata Corporation (6481.T)
• HIWIN Technologies Corp. (2049.TW)
• INTERNATIONAL PAPER CO /NEW/ (IP)
• MinebeaMitsumi Inc. (Mitsumi Electric) (6479.T)
• REGAL REXNORD CORP (RRX)
• SKF (SKF-B.ST)
• Yaskawa Electric Corporation (6506.T)

Frequently asked questions about 共信-KY (6617)

What is 共信-KY (6617)?

共信-KY (6617) is a publicly traded company in the Healthcare sector (生技醫療業), listed on TPEx. Macroplane maps its supply-chain relationships, suppliers, buyers, financial health, and competitive positioning.

Who are 共信-KY's main competitors?

Competitors of 共信-KY (6617) tracked by Macroplane include ALLIENT INC (ALNT), CKD Corporation (6407.T), DANA Inc (DAN), Han's Laser Technology Industry Group Co., Ltd. (002008.SZ), Harmonic Drive Systems Inc. (6324.T), Hirata Corporation (6481.T), HIWIN Technologies Corp. (2049.TW), INTERNATIONAL PAPER CO /NEW/ (IP), and 4 more.